-
Something wrong with this record ?
Computer-assisted engineering of hyperstable fibroblast growth factor 2
P. Dvorak, D. Bednar, P. Vanacek, L. Balek, L. Eiselleova, V. Stepankova, E. Sebestova, M. Kunova Bosakova, Z. Konecna, S. Mazurenko, A. Kunka, T. Vanova, K. Zoufalova, R. Chaloupkova, J. Brezovsky, P. Krejci, Z. Prokop, P. Dvorak, J. Damborsky,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV15-33232A
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2012-07-01 to 1 year ago
PubMed
29278409
DOI
10.1002/bit.26531
Knihovny.cz E-resources
- MeSH
- Point Mutation MeSH
- Computer-Aided Design * MeSH
- Embryonic Stem Cells cytology metabolism MeSH
- Fibroblast Growth Factor 2 chemistry genetics metabolism MeSH
- Humans MeSH
- Computer Simulation MeSH
- Protein Engineering * MeSH
- Directed Molecular Evolution MeSH
- Protein Folding MeSH
- Amino Acid Sequence MeSH
- Protein Stability * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Fibroblast growth factors (FGFs) serve numerous regulatory functions in complex organisms, and their corresponding therapeutic potential is of growing interest to academics and industrial researchers alike. However, applications of these proteins are limited due to their low stability. Here we tackle this problem using a generalizable computer-assisted protein engineering strategy to create a unique modified FGF2 with nine mutations displaying unprecedented stability and uncompromised biological function. The data from the characterization of stabilized FGF2 showed a remarkable prediction potential of in silico methods and provided insight into the unfolding mechanism of the protein. The molecule holds a considerable promise for stem cell research and medical or pharmaceutical applications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035456
- 003
- CZ-PrNML
- 005
- 20201112154542.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/bit.26531 $2 doi
- 035 __
- $a (PubMed)29278409
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Dvorak, Pavel $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Computer-assisted engineering of hyperstable fibroblast growth factor 2 / $c P. Dvorak, D. Bednar, P. Vanacek, L. Balek, L. Eiselleova, V. Stepankova, E. Sebestova, M. Kunova Bosakova, Z. Konecna, S. Mazurenko, A. Kunka, T. Vanova, K. Zoufalova, R. Chaloupkova, J. Brezovsky, P. Krejci, Z. Prokop, P. Dvorak, J. Damborsky,
- 520 9_
- $a Fibroblast growth factors (FGFs) serve numerous regulatory functions in complex organisms, and their corresponding therapeutic potential is of growing interest to academics and industrial researchers alike. However, applications of these proteins are limited due to their low stability. Here we tackle this problem using a generalizable computer-assisted protein engineering strategy to create a unique modified FGF2 with nine mutations displaying unprecedented stability and uncompromised biological function. The data from the characterization of stabilized FGF2 showed a remarkable prediction potential of in silico methods and provided insight into the unfolding mechanism of the protein. The molecule holds a considerable promise for stem cell research and medical or pharmaceutical applications.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a počítačová simulace $7 D003198
- 650 12
- $a design s pomocí počítače $7 D017076
- 650 _2
- $a řízená evoluce molekul $7 D019020
- 650 _2
- $a embryonální kmenové buňky $x cytologie $x metabolismus $7 D053595
- 650 _2
- $a fibroblastový růstový faktor 2 $x chemie $x genetika $x metabolismus $7 D016222
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a bodová mutace $7 D017354
- 650 12
- $a proteinové inženýrství $7 D015202
- 650 _2
- $a sbalování proteinů $7 D017510
- 650 12
- $a stabilita proteinů $7 D055550
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bednar, David $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Vanacek, Pavel $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Balek, Lukas $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Eiselleova, Livia $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Stepankova, Veronika $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Enantis Ltd., Biotechnology Incubator INBIT, Brno, Czech Republic.
- 700 1_
- $a Sebestova, Eva $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Kunova Bosakova, Michaela $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Konecna, Zaneta $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Mazurenko, Stanislav $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Kunka, Antonin $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Vanova, Tereza $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Zoufalova, Karolina $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Chaloupkova, Radka $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Brezovsky, Jan $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Krejci, Pavel $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Prokop, Zbynek $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Dvorak, Petr $u Faculty of Medicine, Department of Biology, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Damborsky, Jiri $u Faculty of Science, Department of Experimental Biology, Loschmidt Laboratories, Centre for Toxic Compounds in the Environment RECETOX, Masaryk University, Brno, Czech Republic. Faculty of Science, Department of Experimental Biology, Masaryk University, Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 773 0_
- $w MED00000795 $t Biotechnology and bioengineering $x 1097-0290 $g Roč. 115, č. 4 (2018), s. 850-862
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29278409 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20201112154539 $b ABA008
- 999 __
- $a ok $b bmc $g 1452116 $s 1074006
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 115 $c 4 $d 850-862 $e 20180124 $i 1097-0290 $m Biotechnology and bioengineering $n Biotechnol Bioeng $x MED00000795
- GRA __
- $a NV15-33232A $p MZ0
- LZP __
- $a Pubmed-20191007